Skip to main content
Signal8

Acquisition of Own Shares

$LKFTPress releaseJun 30, 2026, 4:01 PM ETRead the release

Lakefront Biotherapeutics repurchased 83,530 ordinary shares between June 22 and June 26, 2026, as part of its ongoing share repurchase program. The company paid an aggregate of €2,108,045.52 for the shares, at an average price of €25.24 per share, with prices ranging from €24.38 to €25.82.

Key figures

Shares held
199734
Total spent eur
€2,108,045.52
Average price eur
25.24
Shares repurchased
83530

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    LKFT: Acquisition of Own Shares — AI Analysis | Signal8